Key details Disabling condition: Duchenne muscular dystrophy (DMD) is a severe, genetic condition that causes progressive muscle weakness due to the absence of dystrophin, a protein essential for maintaining muscle integrity. Increasing scientific interest in whether...
Key details Life-limiting condition: Long COVID’s most common symptoms, fatigue and brain fog, can have a strong negative impact on sufferers’ ability to carry out day-to-day activities, reducing quality of life and placing limits on what they are able to accomplish...
Key details Disabling congenital defect: Spina bifida is a birth defect which causes a baby’s spine to not fully close during development, leaving part of the spinal cord exposed. Even with surgical treatment, this condition can result in disability, impacting...
Key details High prevalence of frailty: An estimated 12% to 24% of older adults (people aged 65 and older) suffer from ageing frailty, highlighting a significant unmet medical need. New area of research: A Phase 2b clinical trial has identified laromestrocel, an IV...
Key details High prevalence of injury: Acute radiation dermatitis affects up to 95% of patients undergoing radiotherapy, representing a substantial unmet clinical need.[1] Investigational treatment: A Phase II clinical trial has evaluated a hydrogel containing...
A Milestone Anniversary in Bulgaria Our mission has always been to provide families worldwide with access to the most advanced regenerative medicine and cord blood banking technologies. This month, we are delighted to celebrate a significant milestone in that...
Stem Cell Therapy Potential for Duchenne Muscular Dystrophy
Stem Cell Therapy Shows Promise for Ageing Frailty
Clinical Trial Explores Placental Stem Cell Gel for Radiotherapy Skin Damage
